nach oben

Inflammopharmacology

Erschienen in:

08.01.2022 | Original Article

Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats

verfasst von: Mahendra Kumar Trivedi, Sambhu Mondal, Mayank Gangwar, Snehasis Jana

Erschienen in: Inflammopharmacology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

The study objective was to evaluate the therapeutic effect of cannabidiol (CBD) on a combination of caecal slurry, lipopolysaccharide (LPS), and Escherichia coli (E. coli)-induced systemic inflammatory response syndrome (SIRS) in male Sprague Dawley rats.

Methods

The therapeutic activity was monitored in behavioral tests and inflammatory biomarkers by the enzyme-linked immune sorbent assay (ELISA) method.

Results

Behavioral tasks were significantly increased like a tail flick response by 73.84% (p ≤ 0.001), grip strength by 33.56% (p ≤ 0.028), locomotor activity by 20.71% (p = 0.034) in the CBD (60 mg/kg) group compared to disease control (DC) group. Levels of inflammatory serum biomarkers like interleukin-1β (IL-1β), matrix metallopeptidase-9 (MMP-9), IL-6, and tumor necrosis factor-alpha (TNF-α) were significantly decreased by 29.56 (p = 0.041), 71.20 (p ≤ 0.001), 35.05 (p ≤ 0.001), and 75.56% (p = 0.002), respectively, in the CBD-60 compared with DC. Inflammatory cytokines levels, viz. IL-1β, MMP-9, IL-6, and TNF-α, in the liver were significantly (p ≤ 0.001) decreased by 81.01, 40.41, 22.84, and 69.46%, respectively, in CBD-60 to DC. Similarly, levels of inflammatory cytokines such as IL-1β and MMP-9 in the kidney were significantly (p ≤ 0.001) decreased by 80.90 and 43.93%, respectively, in CBD-60 compared to DC.

Conclusion

Taken together, results suggest that CBD treatment significantly improved behavioral tasks and decreased the level of inflammatory cytokines under SIRS conditions that might provide an opportunity to manage acute and chronic inflammatory disorders.

Graphical abstract

Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840–851CrossRef

Atalay S, Jarocka-Karpowicz I, Skrzydlewska E (2019) Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants (basel). https://doi.org/10.3390/antiox9010021CrossRef

Avraham Y, Grigoriadis N, Poutahidis T, Vorobiev L, Magen I, Ilan Y, Mechoulam R, Berry E (2011) Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. Br J Pharmacol 162(7):1650–1658. https://doi.org/10.1111/j.1476-5381.2010.01179.xCrossRefPubMedPubMedCentral

Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4:854–865CrossRef

Chakraborty RK, Burns B (2021) Systemic inflammatory response syndrome. [Updated 2020 Nov 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547669/. Accessed 8 Nov 2021

De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G (2019) Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain 160(1):136–150. https://doi.org/10.1097/j.pain.0000000000001386CrossRefPubMed

Genaro K, Fabris D, Arantes ALF, Zuardi AW, Crippa JAS, Prado WA (2017) Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats. Front Pharmacol 8:391. https://doi.org/10.3389/fphar.2017.00391CrossRefPubMedPubMedCentral

Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN (2016) Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain 20(6):936–948. https://doi.org/10.1002/ejp.818CrossRefPubMed

Jones NA, Glyn SE, Akiyama S, Hill TD, Hill AJ, Weston SE, Burnett MD, Yamasaki Y, Stephens GJ, Whalley BJ, Williams CM (2012) Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure 21(5):344–352. https://doi.org/10.1016/j.seizure.2012.03.001CrossRefPubMed

Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372(17):1629–1638CrossRef

Lewis AJ, Seymour CW, Rosengart MR (2016) Current murine models of sepsis. Surg Infect (larchmt) 17(4):385–393CrossRef

Maggio M, Guralnik JM, Longo DL, Ferrucci L (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61(6):575–584CrossRef

McPartland JM, Duncan M, Di Marzo V, Pertwee RG (2015) Are cannabidiol and Delta(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol 172(3):737–753. https://doi.org/10.1111/bph.12944CrossRefPubMedPubMedCentral

Mlost J, Bryk M, Starowicz K (2020) Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci 21(22):8870. https://doi.org/10.3390/ijms21228870/CrossRefPubMedCentral

Opal SM (2010) Endotoxins and other sepsis triggers. Contrib Nephrol 167:14–24CrossRef

Park KS, Choi KH, Kim YS, Hong BS, Kim OY, Kim JH, Yoon CM, Koh GY, Kim YK, Gho YS (2010) Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS ONE 5(6):e11334. https://doi.org/10.1371/journal.pone.0011334CrossRefPubMedPubMedCentral

Ramabadran K, Bansinath M, Turndorf H, Puig MM (1989) Tail immersion test for the evaluation of a nociceptive reaction in mice. Methodological considerations. J Pharmacol Methods 21(1):21–31CrossRef

Ramnath RD, Weing S, He M, Sun J, Zhang H, Singh Bawa M, Bhatia M (2006) Inflammatory mediators in sepsis: cytokines, chemokines, adhesion molecules and gases. J Organ Dysfunct 2(2):80–92CrossRef

Schleicher EM, Ott FW, Müller M, Silcher B, Sichler ME, Löw MJ, Wagner JM, Bouter Y (2019) Prolonged cannabidiol treatment lacks on detrimental effects on memory, motor performance and anxiety in C57BL/6J mice. Front Behav Neurosci 7(13):94. https://doi.org/10.3389/fnbeh.2019.00094CrossRef

Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu Y, Ikeda K, Takahashi R, Kitazawa S, Hattori N (2010) A rotarod test for evaluation of motor skill learning. J Neurosci Methods 189(2):180–185CrossRef

Starr ME, Steele AM, Saito M, Hacker BJ, Evers BM, Saito H (2014) A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis. PLoS ONE. https://doi.org/10.1371/journal.pone.0115705CrossRefPubMedPubMedCentral

Sun A, Chia JS, Chang YF, Chiang CP (2002) Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med 31(4):196–203CrossRef

Suryavanshi SV, Kovalchuk I, Kovalchuk O (2021) Cannabinoids as key regulators of inflammasome signaling: a current perspective. Front Immunol 11:613613. https://doi.org/10.3389/fimmu.2020.613613CrossRefPubMedPubMedCentral

Takac B, Mihaljević S, Stefanić M, Glavas-Obrovac L, Kibel A, Samardzija M (2014) Importance of interleukin 6 in pathogenesis of inflammatory bowel disease. Coll Antropol 38(2):659–664PubMed

Tatem KS, Quinn JL, Phadke A, Yu Q, Gordish-Dressman H, Nagaraju K (2014) Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J vis Exp 91:51785

Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB₁ and CB₂ receptor agonists in vitro. Br J Pharmacol 150(5):613–623. https://doi.org/10.1038/sj.bjp.0707133CrossRefPubMedPubMedCentral

Vincent JL, Opal SM, Marshall JC, Tracey KJ (2013) Sepsis definitions: time for change. Lancet 381(9868):774–775CrossRef

Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, Guan Y, Pan HL, Ren K, Xu Y, Zhang LJ (2012) Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. Exp Med 209(6):1121–1134CrossRef

Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 80(6):607–613. https://doi.org/10.1016/j.jinf.2020.03.037CrossRefPubMedPubMedCentral

Young WA, Fallon EA, Heffernan DS, Efron PA, Cioffi WG, Ayala A (2017) Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates. Surgery 161(5):1387–1393CrossRef

Titel: Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats
verfasst von: Mahendra Kumar Trivedi
Sambhu Mondal
Mayank Gangwar
Snehasis Jana
Publikationsdatum: 08.01.2022
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 1/2022
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-021-00901-z

Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis

Original Article

Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion

Original Article

Pathophysiological basis in the management of myasthenia gravis: a mini review

Review

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

Zur Zeit gratis
COVID-19
Correction

Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α production

Original Article

Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases

Review

Springer Medizin

Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats

Abstract

Objective

Methods

Results

Conclusion

Graphical abstract

Weitere Artikel der Ausgabe 1/2022

Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis

Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion

Pathophysiological basis in the management of myasthenia gravis: a mini review

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α production

Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis

Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion

Pathophysiological basis in the management of myasthenia gravis: a mini review

Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α production

Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases